Hereditary Testing Market Size, Share & Trends Analysis Report By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing), By Technology (Cytogenetic, Biochemical, Molecular Testing), By Region, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Hereditary Testing Market: Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Disease Type
    • 1.1.1.2. Technology Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
  • 1.4.3. Objective - 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Hereditary Testing Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Disease Type Technology Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Hereditary Testing Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers Analysis
  • 3.4.1. Increase in sales and demand for DNA test kits
  • 3.4.2. Constantly developing commercial landscape of women's reproductive health
  • 3.4.3. Decline in sequencing cost & consequent expansion of genetic testing registry
• 3.5. Market Restraint Analysis
  • 3.5.1. Ethical and clinical issues of DNA tests
  • 3.5.2. Regulatory challenges pertaining to use of DTC genetic tests
• 3.6. Market Opportunity Analysis
  • 3.6.1. Increasing incidence of genetic diseases
  • 3.6.2. Presence of demand for early and non-invasive fetal testing procedures
  • 3.6.3. Introduction of fragmented point-solutions across the genomics value chain
• 3.7. Porter's Five Forces Analysis
• 3.8. PESTLE Analysis
• 3.9. Pipeline Analysis

Chapter 4. Hereditary Testing Market: Disease Type Estimates & Trend Analysis

• 4.1. Hereditary Testing Market: Disease Type Movement Analysis
• 4.2. Hereditary Cancer Testing
  • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.2. Breast Cancer
    • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.3. Lung Cancer
    • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.4. Colorectal Cancer
    • 4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.5. Cervical Cancer
    • 4.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.6. Ovarian Cancer
    • 4.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.7. Prostate Cancer
    • 4.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.8. Stomach/Gastric Cancer
    • 4.2.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.9. Melanoma
    • 4.2.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.10. Sarcoma
    • 4.2.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.11. Uterine Cancer
    • 4.2.11.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.12. Pancreatic Cancer
    • 4.2.12.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.2.13. Others
    • 4.2.13.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.3. Hereditary Non-cancer Testing
  • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Genetic Tests
    • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.2. Cardiac Diseases
      • 4.3.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.3. Rare Diseases
      • 4.3.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2.4. Other Diseases
      • 4.3.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Preimplantation Genetic Diagnosis & Screening
    • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
    • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.5. Newborn Genetic Screening
    • 4.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hereditary Testing Market: Technology Estimates & Trend Analysis

• 5.1. Hereditary Testing Market: Technology Movement Analysis
• 5.2. Cytogenetic
  • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.3. Biochemical
  • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Molecular Testing
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hereditary Testing Market: Regional Business Analysis

• 6.1. Regional Market Snapshot
• 6.2. North America
  • 6.2.1. North America Hereditary Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.2.2.2. Key Country Dynamics
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. Reimbursement Scenario
    • 6.2.2.5. Competitive Scenario
  • 6.2.3. Canada
    • 6.2.3.1. Canada Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.2.3.2. Key Country Dynamics
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Reimbursement Scenario
    • 6.2.3.5. Competitive Scenario
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.2.4.2. Key Country Dynamics
    • 6.2.4.3. Regulatory Framework
    • 6.2.4.4. Reimbursement Scenario
    • 6.2.4.5. Competitive Scenario
• 6.3. Europe
  • 6.3.1. Europe Hereditary Testing Market, 2021 - 2033 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.2.2. Key Country Dynamics
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. Reimbursement Scenario
    • 6.3.2.5. Competitive Scenario
  • 6.3.3. Germany
    • 6.3.3.1. Germany Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.3.2. Key Country Dynamics
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Reimbursement Scenario
    • 6.3.3.5. Competitive Scenario
  • 6.3.4. Spain
    • 6.3.4.1. Spain Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.4.2. Key Country Dynamics
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. Reimbursement Scenario
    • 6.3.4.5. Competitive Scenario
  • 6.3.5. France
    • 6.3.5.1. France Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.5.2. Key Country Dynamics
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Reimbursement Scenario
    • 6.3.5.5. Competitive Scenario
  • 6.3.6. Italy
    • 6.3.6.1. Italy Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.6.2. Key Country Dynamics
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Reimbursement Scenario
    • 6.3.6.5. Competitive Scenario
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.7.2. Key Country Dynamics
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Reimbursement Scenario
    • 6.3.7.5. Competitive Scenario
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.8.2. Key Country Dynamics
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Reimbursement Scenario
    • 6.3.8.5. Competitive Scenario
  • 6.3.9. Norway
    • 6.3.9.1. Norway Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.3.9.2. Key Country Dynamics
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Reimbursement Scenario
    • 6.3.9.5. Competitive Scenario
• 6.4. Asia Pacific
  • 6.4.1. Asia-Pacific Hereditary Testing Market, 2021 - 2033 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Japan Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.4.2.2. Key Country Dynamics
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Reimbursement Scenario
    • 6.4.2.5. Competitive Scenario
  • 6.4.3. China
    • 6.4.3.1. China Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.4.3.2. Key Country Dynamics
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Reimbursement Scenario
    • 6.4.3.5. Competitive Scenario
  • 6.4.4. India
    • 6.4.4.1. India Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.4.4.2. Key Country Dynamics
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Reimbursement Scenario
    • 6.4.4.5. Competitive Scenario
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.4.5.2. Key Country Dynamics
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Reimbursement Scenario
    • 6.4.5.5. Competitive Scenario
  • 6.4.6. Thailand
    • 6.4.6.1. Thailand Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.4.6.2. Key Country Dynamics
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Reimbursement Scenario
    • 6.4.6.5. Competitive Scenario
  • 6.4.7. Australia
    • 6.4.7.1. Australia Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.4.7.2. Key Country Dynamics
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Reimbursement Scenario
    • 6.4.7.5. Competitive Scenario
• 6.5. Latin America
  • 6.5.1. Latin America Hereditary Testing Market, 2021 - 2033 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.5.2.2. Key Country Dynamics
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement Scenario
    • 6.5.2.5. Competitive Scenario
  • 6.5.3. Argentina
    • 6.5.3.1. Argentina Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.5.3.2. Key Country Dynamics
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement Scenario
    • 6.5.3.5. Competitive Scenario
• 6.6. Middle East & Africa
  • 6.6.1. Middle East & Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.6.2.2. Key Country Dynamics
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement Scenario
    • 6.6.2.5. Competitive Scenario
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.6.3.2. Key Country Dynamics
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement Scenario
    • 6.6.3.5. Competitive Scenario
  • 6.6.4. UAE
    • 6.6.4.1. UAE Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.6.4.2. Key Country Dynamics
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement Scenario
    • 6.6.4.5. Competitive Scenario
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Hereditary Testing Market, 2021 - 2033 (USD Million)
    • 6.6.5.2. Key Country Dynamics
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement Scenario
    • 6.6.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
  • 7.2.1. New Product Launch
  • 7.2.2. Partnerships
  • 7.2.3. Acquisition
  • 7.2.4. Collaboration
  • 7.2.5. Funding
• 7.3. Key Company Market Share Analysis, 2024
• 7.4. Company Heat Map Analysis
• 7.5. Company Profiles
  • 7.5.1. Myriad Genetics, Inc.
    • 7.5.1.1. Company Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Invitae Corporation
    • 7.5.2.1. Company Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Illumina, Inc.
    • 7.5.3.1. Company Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Natera, Inc.
    • 7.5.4.1. Company Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Laboratory Corporation of America Holdings
    • 7.5.5.1. Company Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. F. Hoffmann-La Roche Ltd.
    • 7.5.6.1. Company Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Quest Diagnostics Incorporated
    • 7.5.7.1. Company Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. COOPERSURGICAL, INC.
    • 7.5.8.1. Company Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Agilent Technologies, Inc.
    • 7.5.9.1. Company Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Thermo Fisher Scientific, Inc.
    • 7.5.10.1. Company Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives
  • 7.5.11. Twist Bioscience
    • 7.5.11.1. Company Overview
    • 7.5.11.2. Financial Performance
    • 7.5.11.3. Product Benchmarking
    • 7.5.11.4. Strategic Initiatives
  • 7.5.12. SOPHiA GENETICS
    • 7.5.12.1. Company Overview
    • 7.5.12.2. Financial Performance
    • 7.5.12.3. Product Benchmarking
    • 7.5.12.4. Strategic Initiatives
  • 7.5.13. Fulgent Genetics
    • 7.5.13.1. Company Overview
    • 7.5.13.2. Financial Performance
    • 7.5.13.3. Product Benchmarking
    • 7.5.13.4. Strategic Initiatives
  • 7.5.14. MedGenome
    • 7.5.14.1. Company Overview
    • 7.5.14.2. Financial Performance
    • 7.5.14.3. Product Benchmarking
    • 7.5.14.4. Strategic Initiatives
  • 7.5.15. CENTOGENE N.V.
    • 7.5.15.1. Company Overview
    • 7.5.15.2. Financial Performance
    • 7.5.15.3. Product Benchmarking
    • 7.5.15.4. Strategic Initiatives

List of Tables

• Table 1 Product mapping for hereditary cancer tests
• Table 2 DNA sequencing costs over the past decade
• Table 3 Global incidence rate of genetic disorders
• Table 4 Technology landscape for NIPT tests
• Table 5 Comparison of other technologies
• Table 6 Countries that prescribe mandatory medical supervision & restriction for genetic tests
• Table 7 Susceptibility genes and their prevalence in hereditary ovarian syndromes
• Table 8 Various NGS tests for hereditary prostate cancer
• Table 9 Genetic testing scenario for patients/families affected by inherited cardiac disease
• Table 10 Financial solutions for PGT:
• Table 11 Commercial landscape of NIPT for fetal aneuploidy in the U.S.
• Table 12 North America hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 16 North America hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 17 U.S. hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 18 U.S. hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 19 Canada hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 20 Canada hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 21 Mexico hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 22 Mexico hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 23 Europe hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 35 Europe hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 36 UK hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 37 UK hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 38 Germany hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 39 Germany hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 40 France hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 41 France hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 42 Spain hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 43 Spain hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 43 Italy hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 44 Italy hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 45 Denmark hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 46 Denmark hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 47 Sweden hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 48 Sweden hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 49 Norway hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 50 Norway hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 51 Asia Pacific hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 52 Asia Pacific hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 53 China hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 54 China hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 55 Japan hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 56 Japan hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 57 India hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 58 India hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 59 South Korea hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 60 South Korea hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 61 Australia hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 62 Australia hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 63 Thailand hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 64 Thailand hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 65 Latin America hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 66 Latin America hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 67 Brazil hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 68 Brazil hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 69 Argentina hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 70 Argentina hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 71 Middle East & Africa hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 72 Middle East & Africa hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 73 South Africa hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 74 South Africa hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 75 Saudi Arabia hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 76 Saudi Arabia hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 77 UAE hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 79 UAE hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)
• Table 80 Kuwait hereditary testing market estimates & forecasts, by disease type, 2021 - 2033 (USD Million)
• Table 81 Kuwait hereditary testing market estimates & forecasts, by technology, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Hereditary Testing Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 11 Penetration & Growth Prospect Mapping
• Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 13 Porter's Five Forces Analysis
• Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2024
• Fig. 15 Regional Marketplace: Key Takeaways
• Fig. 16 Regional Outlook, 2024 & 2033
• Fig. 17 North America Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 18 U.S. Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 19 Mexico Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 19 Canada Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 20 Europe Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 21 Germany Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 22 UK Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 23 France Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 24 Spain Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 25 Italy Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 26 Denmark Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 27 Sweden Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 28 Norway Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 29 Asia Pacific Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 30 Japan Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 31 China Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 32 India Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 33 Australia Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 34 South Korea Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 35 Thailand Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 36 Latin America Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 37 Brazil Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 39 Argentina Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 40 Middle East and Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 41 South Africa Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 42 Saudi Arabia Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 43 UAE Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 44 Kuwait Hereditary Testing Market, 2021 - 2033 (USD Million)
• Fig. 45 Global Hereditary Testing Market, for, Hereditary Cancer Testing 2021 - 2033 (USD Million)
• Fig. 46 Global Hereditary Testing Market, for, Lung Cancer 2021 - 2033 (USD Million)
• Fig. 47 Global Hereditary Testing Market, for, Breast Cancer 2021 - 2033 (USD Million)
• Fig. 48 Global Hereditary Testing Market, for, Colorectal Cancer 2021 - 2033 (USD Million)
• Fig. 49 Global Hereditary Testing Market, for, Cervical Cancer 2021 - 2033 (USD Million)
• Fig. 50 Global Hereditary Testing Market, for, Ovarian Cancer 2021 - 2033 (USD Million)
• Fig. 51 Global Hereditary Testing Market, for, Prostate Cancer 2021 - 2033 (USD Million)
• Fig. 52 Global Hereditary Testing Market, for, Stomach/Gastric Cancer 2021 - 2033 (USD Million)
• Fig. 53 Global Hereditary Testing Market, for, Melanoma 2021 - 2033 (USD Million)
• Fig. 54 Global Hereditary Testing Market, for, Sarcoma 2021 - 2033 (USD Million)
• Fig. 55 Global Hereditary Testing Market, for, Uterine Cancer 2021 - 2033 (USD Million)
• Fig. 56 Global Hereditary Testing Market, for, Pancreatic Cancer 2021 - 2033 (USD Million)
• Fig. 57 Global Hereditary Testing Market, for, Others 2021 - 2033 (USD Million)
• Fig. 58 Global Hereditary Testing Market, for, Genetic Tests 2021 - 2033 (USD Million)
• Fig. 59 Global Hereditary Testing Market, for, Cardiac Diseases 2021 - 2033 (USD Million)
• Fig. 60 Global Hereditary Testing Market, for, Rare Diseases 2021 - 2033 (USD Million)
• Fig. 61 Global Hereditary Testing Market, for, Other Diseases 2021 - 2033 (USD Million)
• Fig. 62 Global Hereditary Testing Market, for, Newborn Genetic Screening 2021 - 2033 (USD Million)
• Fig. 63 Global Hereditary Testing Market, for, Preimplantation Genetic Diagnosis & Screening 2021 - 2033 (USD Million)
• Fig. 64 Global Hereditary Testing Market, for, Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests 2021 - 2033 (USD Million)
• Fig. 65 Global Hereditary Testing Market, for, Cytogenetic 2021 - 2033 (USD Million)
• Fig. 66 Global Hereditary Testing Market, for, Biochemical 2021 - 2033 (USD Million)
• Fig. 67 Global Hereditary Testing Market, for, Molecular Testing 2021 - 2033 (USD Million)